BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

607 related articles for article (PubMed ID: 27407135)

  • 1. Pro-inflammatory S100 proteins are associated with glomerulonephritis and anti-dsDNA antibodies in systemic lupus erythematosus.
    Tydén H; Lood C; Gullstrand B; Jönsen A; Ivars F; Leanderson T; Bengtsson AA
    Lupus; 2017 Feb; 26(2):139-149. PubMed ID: 27407135
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased serum levels of S100A8/A9 and S100A12 are associated with cardiovascular disease in patients with inactive systemic lupus erythematosus.
    Tydén H; Lood C; Gullstrand B; Jönsen A; Nived O; Sturfelt G; Truedsson L; Ivars F; Leanderson T; Bengtsson AA
    Rheumatology (Oxford); 2013 Nov; 52(11):2048-55. PubMed ID: 23942785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urine and serum S100A8/A9 and S100A12 associate with active lupus nephritis and may predict response to rituximab treatment.
    Davies JC; Midgley A; Carlsson E; Donohue S; Bruce IN; Beresford MW; Hedrich CM
    RMD Open; 2020 Jul; 6(2):. PubMed ID: 32723832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated S100A8/A9 and S100A12 Serum Levels Reflect Intraocular Inflammation in Juvenile Idiopathic Arthritis-Associated Uveitis: Results From a Pilot Study.
    Walscheid K; Heiligenhaus A; Holzinger D; Roth J; Heinz C; Tappeiner C; Kasper M; Foell D
    Invest Ophthalmol Vis Sci; 2015 Dec; 56(13):7653-60. PubMed ID: 26624497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phagocyte-specific S100A8/A9 protein levels during disease exacerbations and infections in systemic lupus erythematosus.
    Soyfoo MS; Roth J; Vogl T; Pochet R; Decaux G
    J Rheumatol; 2009 Oct; 36(10):2190-4. PubMed ID: 19755614
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential analysis of serum and urine S100 proteins in juvenile-onset systemic lupus erythematosus (jSLE).
    Donohue SJ; Midgley A; Davies JC; Wright RD; Bruce I; Beresford MW; Hedrich CM; ;
    Clin Immunol; 2020 May; 214():108375. PubMed ID: 32135275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hydroxychloroquine modulates elevated expression of S100 proteins in systemic lupus erythematosus.
    Wakiya R; Kameda T; Ueeda K; Nakashima S; Shimada H; Mansour MF; Kato M; Miyagi T; Miyatake N; Kadowaki N; Dobashi H
    Lupus; 2019 Jun; 28(7):826-833. PubMed ID: 31068068
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protein synthesis of the pro-inflammatory S100A8/A9 complex in plasmacytoid dendritic cells and cell surface S100A8/A9 on leukocyte subpopulations in systemic lupus erythematosus.
    Lood C; Stenström M; Tydén H; Gullstrand B; Källberg E; Leanderson T; Truedsson L; Sturfelt G; Ivars F; Bengtsson AA
    Arthritis Res Ther; 2011 Apr; 13(2):R60. PubMed ID: 21492422
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating S100 proteins effectively discriminate SLE patients from healthy controls: a cross-sectional study.
    Šumová B; Cerezo LA; Szczuková L; Nekvindová L; Uher M; Hulejová H; Moravcová R; Grigorian M; Pavelka K; Vencovský J; Šenolt L; Závada J
    Rheumatol Int; 2019 Mar; 39(3):469-478. PubMed ID: 30392117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet-Derived S100A8/A9 and Cardiovascular Disease in Systemic Lupus Erythematosus.
    Lood C; Tydén H; Gullstrand B; Jönsen A; Källberg E; Mörgelin M; Kahn R; Gunnarsson I; Leanderson T; Ivars F; Svenungsson E; Bengtsson AA
    Arthritis Rheumatol; 2016 Aug; 68(8):1970-80. PubMed ID: 26946461
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospective evaluation of S100A12 and S100A8/A9 (calprotectin) in dogs with sepsis or the systemic inflammatory response syndrome.
    Thames BE; Barr JW; Suchodolski JS; Steiner JM; Heilmann RM
    J Vet Diagn Invest; 2019 Jul; 31(4):645-651. PubMed ID: 31170888
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum S100A8/A9 and S100A12 Levels in Children With Polyarticular Forms of Juvenile Idiopathic Arthritis: Relationship to Maintenance of Clinically Inactive Disease During Anti-Tumor Necrosis Factor Therapy and Occurrence of Disease Flare After Discontinuation of Therapy.
    Hinze CH; Foell D; Johnson AL; Spalding SJ; Gottlieb BS; Morris PW; Kimura Y; Onel K; Li SC; Grom AA; Taylor J; Brunner HI; Huggins JL; Nocton JJ; Haines KA; Edelheit BS; Shishov M; Jung LK; Williams CB; Tesher MS; Costanzo DM; Zemel LS; Dare JA; Passo MH; Ede KC; Olson JC; Cassidy EA; Griffin TA; Wagner-Weiner L; Weiss JE; Vogler LB; Rouster-Stevens KA; Beukelman T; Cron RQ; Kietz D; Schikler K; Mehta J; Ting TV; Verbsky JW; Eberhard AB; Huang B; Giannini EH; Lovell DJ
    Arthritis Rheumatol; 2019 Mar; 71(3):451-459. PubMed ID: 30225949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of anti-nucleosome antibodies in the diagnosis of systemic lupus erythematosus and as a marker for lupus nephropathy.
    Abdel Gawad ER; Mansour AI; Abdel Aziz YA; Soliman AF; Fawzy RM
    Egypt J Immunol; 2014; 21(1):57-65. PubMed ID: 25204045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mucosal expression of S100A12 (calgranulin C) and S100A8/A9 (calprotectin) and correlation with serum and fecal concentrations in dogs with chronic inflammatory enteropathy.
    Heilmann RM; Nestler J; Schwarz J; Grützner N; Ambrus A; Seeger J; Suchodolski JS; Steiner JM; Gurtner C
    Vet Immunol Immunopathol; 2019 May; 211():64-74. PubMed ID: 31084897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Different expression ratio of S100A8/A9 and S100A12 in acute and chronic lung diseases.
    Lorenz E; Muhlebach MS; Tessier PA; Alexis NE; Duncan Hite R; Seeds MC; Peden DB; Meredith W
    Respir Med; 2008 Apr; 102(4):567-73. PubMed ID: 18164192
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calprotectin (S100A8/A9) and S100A12 are associated with measures of disease activity in a longitudinal study of patients with rheumatoid arthritis treated with infliximab.
    Nordal HH; Brun JG; Hordvik M; Eidsheim M; Jonsson R; Halse AK
    Scand J Rheumatol; 2016 Jul; 45(4):274-81. PubMed ID: 26767827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum levels of soluble receptor for advanced glycation end products and of S100 proteins are associated with inflammatory, autoantibody, and classical risk markers of joint and vascular damage in rheumatoid arthritis.
    Chen YS; Yan W; Geczy CL; Brown MA; Thomas R
    Arthritis Res Ther; 2009; 11(2):R39. PubMed ID: 19284577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neutrophil Extracellular Trap Mitochondrial DNA and Its Autoantibody in Systemic Lupus Erythematosus and a Proof-of-Concept Trial of Metformin.
    Wang H; Li T; Chen S; Gu Y; Ye S
    Arthritis Rheumatol; 2015 Dec; 67(12):3190-200. PubMed ID: 26245802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. C-reactive protein is a more sensitive and specific marker for diagnosing bacterial infections in systemic lupus erythematosus compared to S100A8/A9 and procalcitonin.
    Kim HA; Jeon JY; An JM; Koh BR; Suh CH
    J Rheumatol; 2012 Apr; 39(4):728-34. PubMed ID: 22337236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High expression of S100 calgranulin genes in peripheral blood mononuclear cells from patients with Takayasu arteritis.
    Kabeerdoss J; Thomas M; Goel R; Mohan H; Danda S; L J; Danda D
    Cytokine; 2019 Feb; 114():61-66. PubMed ID: 30594066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.